RIPK1 and neoplasm: In addition to the core biomarkers (RIPK1, RIPK3, and MLKL), other functionally significant genes, such as ZBP1, TLR3, and PYGL, are also associated with KIRC progression and play important roles in promoting tumor proliferation during disease development (19–21).